Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2010 1
2011 1
2012 4
2013 1
2014 3
2015 8
2016 8
2017 8
2018 12
2019 18
2020 12
2021 20
2022 15
2023 17
2024 17
2025 18
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

150 results

Results by year

Filters applied: . Clear all
Page 1
Pathological angiogenesis in retinopathy engages cellular senescence and is amenable to therapeutic elimination via BCL-xL inhibition.
Crespo-Garcia S, Tsuruda PR, Dejda A, Ryan RD, Fournier F, Chaney SY, Pilon F, Dogan T, Cagnone G, Patel P, Buscarlet M, Dasgupta S, Girouard G, Rao SR, Wilson AM, O'Brien R, Juneau R, Guber V, Dubrac A, Beausejour C, Armstrong S, Mallette FA, Yohn CB, Joyal JS, Marquess D, Beltran PJ, Sapieha P. Crespo-Garcia S, et al. Among authors: patel p. Cell Metab. 2021 Apr 6;33(4):818-832.e7. doi: 10.1016/j.cmet.2021.01.011. Epub 2021 Feb 5. Cell Metab. 2021. PMID: 33548171 Free article.
Dual SORT LNPs for multi-organ base editing.
Kim M, Song ES, Chen JC, Chatterjee S, Sun Y, Lee SM, Wu S, Patel P, Tian Z, Kantor A, Wustman BA, Lockhart DJ, Siegwart DJ. Kim M, et al. Among authors: patel p. Nat Biotechnol. 2026 Apr;44(4):578-586. doi: 10.1038/s41587-025-02675-z. Epub 2025 Jun 2. Nat Biotechnol. 2026. PMID: 40457105
Therapeutic targeting of cellular senescence in diabetic macular edema: preclinical and phase 1 trial results.
Crespo-Garcia S, Fournier F, Diaz-Marin R, Klier S, Ragusa D, Masaki L, Cagnone G, Blot G, Hafiane I, Dejda A, Rizk R, Juneau R, Buscarlet M, Chorfi S, Patel P, Beltran PJ, Joyal JS, Rezende FA, Hata M, Nguyen A, Sullivan L, Damiano J, Wilson AM, Mallette FA, David NE, Ghosh A, Tsuruda PR, Dananberg J, Sapieha P. Crespo-Garcia S, et al. Among authors: patel p. Nat Med. 2024 Feb;30(2):443-454. doi: 10.1038/s41591-024-02802-4. Epub 2024 Feb 6. Nat Med. 2024. PMID: 38321220 Clinical Trial.
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.
Parker CC, Kynaston H, Cook AD, Clarke NW, Catton CN, Cross WR, Petersen PM, Persad RA, Pugh CA, Saad F, Logue J, Payne H, Bower LC, Brawley C, Rauchenberger M, Barkati M, Bottomley DM, Brasso K, Chung HT, Chung PWM, Conroy R, Falconer A, Ford V, Goh CL, Heath CM, James ND, Kim-Sing C, Kodavatiganti R, Malone SC, Morris SL, Nabid A, Ong AD, Raman R, Rodda S, Wells P, Worlding J, Parulekar WR, Parmar MKB, Sydes MR; RADICALS investigators. Parker CC, et al. Lancet. 2024 Jun 1;403(10442):2416-2425. doi: 10.1016/S0140-6736(24)00549-X. Epub 2024 May 16. Lancet. 2024. PMID: 38763153 Free PMC article. Clinical Trial.
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.
Parker CC, Clarke NW, Cook AD, Kynaston H, Catton CN, Cross WR, Petersen PM, Persad RA, Saad F, Bower LC, Logue J, Payne H, Forcat S, Goldstein C, Murphy C, Anderson J, Barkati M, Bottomley DM, Branagan J, Choudhury A, Chung PWM, Cogley L, Goh CL, Hoskin P, Khoo V, Malone SC, Masters L, Morris SL, Nabid A, Ong AD, Raman R, Tarver KL, Tree AC, Worlding J, Wylie JP, Zarkar AM, Parulekar WR, Parmar MKB, Sydes MR; RADICALS investigators. Parker CC, et al. Lancet. 2024 Jun 1;403(10442):2405-2415. doi: 10.1016/S0140-6736(24)00548-8. Epub 2024 May 16. Lancet. 2024. PMID: 38763154 Free PMC article. Clinical Trial.
Antibody-Drug Conjugates in Bladder Cancer.
Vlachostergios PJ, Jakubowski CD, Niaz MJ, Lee A, Thomas C, Hackett AL, Patel P, Rashid N, Tagawa ST. Vlachostergios PJ, et al. Among authors: patel p. Bladder Cancer. 2018 Jul 30;4(3):247-259. doi: 10.3233/BLC-180169. Bladder Cancer. 2018. PMID: 30112436 Free PMC article. Review.
Pediatric Laser Therapy in Pigmented Conditions.
Patel PD, Mohan GC, Bhattacharya T, Patel RA, Tsoukas M. Patel PD, et al. Am J Clin Dermatol. 2019 Oct;20(5):647-655. doi: 10.1007/s40257-019-00449-3. Am J Clin Dermatol. 2019. PMID: 31134589 Review.
Typhoid conjugate vaccines: making vaccine history in Africa.
Meiring JE, Patel P, Patel P, Gordon MA. Meiring JE, et al. Among authors: patel p. Expert Rev Vaccines. 2018 Aug;17(8):673-676. doi: 10.1080/14760584.2018.1496825. Epub 2018 Jul 23. Expert Rev Vaccines. 2018. PMID: 29972655 No abstract available.
Endogenous Targeting of Lipid Nanoparticles to Kidney Tumors.
Vaidya A, Sung YC, Toffessi Tcheuyap V, Zhang C, Butti R, Mal A, Dilliard S, Liu J, Song E, Guerrero E, Patel P, Santelli J, Miyata J, Moore S, Chatterjee S, Prakasam G, Xiao Y, Kapur P, Brugarolas J, Siegwart DJ. Vaidya A, et al. Among authors: patel p. ACS Nano. 2025 Sep 2;19(34):30860-30871. doi: 10.1021/acsnano.5c05370. Epub 2025 Aug 20. ACS Nano. 2025. PMID: 40835583 Free PMC article.
150 results